Xencor Names Bart Cornelissen as SVP and Chief Financial Officer

Xencor Inc., a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, has appointed Bart Cornelissen [alumnus RSM MScBA] as senior vice president and chief financial officer.

Read the article: https://www.contractpharma.com/contents/view_breaking-news/2024-04-09/xencor-names-bart-cornelissen-as-svp-and-chief-financial-officer/

Participants

  • Bart Cornelissen
    Role: Alumni
    Reference type: Featured

Media Outlets

  • Contract Pharma (Online)